Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Peritoneal Neoplasms × Magnetic Resonance Spectroscopy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 4 Lung Neoplasms 4 Oropharyngeal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Mouth Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Colorectal Neoplasms 2 Carcinoma 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stage II Prostate Adenocarcinoma 1 Sarcoma, Ewing 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Prostate Adenocarcinoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Nasopharyngeal Carcinoma 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoid Interstitial Pneumonia 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1

Interventions

Standard of Care 1 Specimen Handling 1 Practice Guidelines as Topic 1 Magnetic Resonance Spectroscopy 1 Laparoscopy 1 Hyperthermic Intraperitoneal Chemotherapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07001748 2026-03-23

STOPGAP II

Eastern Cooperative Oncology Group

Phase 2/3 Recruiting

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡